Case presentation
6
/kg, CFU-GM 6.8 × 10 4 kg) following conditioning with Bu 4 mg/kg/day for 4 days and CY 50 mg/kg/day Diamond-Blackfan anemia (DBA) is a rare disease with for 3 days. With the exception of a single episode of fever hypoplastic, macrocytic anemia being its dominant feature.
of unknown origin, the transplant period was uneventful. Although the cause and pathogenesis of DBA remain to ANC of over 200 × 10 6 /l and 500 × 10 6 /l were reached on be delineated, most patients have a selective deficiency of days 27 and 34 post-transplant, respectively. No CSF was marrow erythroid progenitors.
1 Spontaneous recoveries do employed. The platelets were self-sustaining (over occur in up to 20% of patients. Out of those treated with 30 × 10 9 /l) after 6 weeks. The patient received his last unit corticosteroids, up to 50% remain refractory or mediof red cells on day 36 and presented his first circulating cation-dependent. 2 reticulocytes on day 17 post-transplant, subsequently Bone marrow transplantation has been successfully developing fully normal erythropoiesis. No signs of either employed in the treatment of DBA.
3,4 However, even in an acute or chronic GVHD were encountered during the fol-HLA-identical sibling setting the procedure involves conlow-up, currently at 23 months. Complete chimerism was siderable toxicity including both acute and chronic GVHD. verified through ABO analysis 75 days post-transplant. During the past 8 years, cord blood stem cell transplanAs prevention for GVHD, he received a total of four tation has emerged as a viable option for marrow reconstidoses of i.v. MTX (first, 15 mg/m 2 , second to fourth tution following myeloablative therapy. 5 The first success-10 mg/m 2 ) on days 1, 3, 6 and 11 post-transplant, respectful cord blood stem cell transplant was performed in a ively. patient with Fanconi anemia. 6 Since then, several patients He was discharged on day 42 and since then his followwith non-malignant marrow diseases have been transup has been uneventful with a Karnofsky performance planted. 5 The experience gathered suggests the risk of score of 100%. GVHD following cord blood stem cell transplantation is Currently his Hb is 14 g/dl, WBC 6.9 × 10 9 /l, ANC substantially less than that related to bone marrow trans-1863 × 10 6 /l and thrombocytes 151 × 10 9 /l. plantation. 5 We present a case of Diamond-Blackfan anemia successfully treated by cord blood stem cell transplant from an HLA-identical sibling. Discussion
With the option of cord blood stem cell transplantation being available for curative treatment of DBA, it may be The same currently appears to hold true for a number of References other malignant and non-malignant marrow disorders.
5
A decrease in treatment-related toxicity is particularly engraftment.
